Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Advent Life Sciences

Advent Life Sciences
VC INVESTOR TYPE
Active STATUS
6 PROFESSIONALS
66 INVESTMENTS
22 PORTFOLIO
31 EXITS
Description

Advent Life Sciences is a venture capital firm which seeks to invest in early and mid-stage life sciences firms. The firm focuses in new drug discovery, small molecules, biologics and new modalities, med tech, enabling technologies and vaccines.

Investor Status
Actively Seeking New Investments
Year Founded
2009
Primary Investor Type
Venture Capital
Primary Office
  • 158-160 North Gower Street
  • London NW1 2ND
  • England, United Kingdom

+44 020 0000 0000

Advent Life Sciences Investments (66)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
MiroBio 07-Oct-2019 Early Stage VC 000.00 Biotechnology Startup 0000000 00000 00
00000 000000000000 27-Jun-2019 00000 00000 00.000 Drug Discovery Startup
000000 0000000 20-Jun-2019 00000 00000 00000 Diagnostic Equipment Generating Revenue 0000000 00000 00
000000-000 04-Jun-2019 0000 00000 00.000 Drug Discovery Generating Revenue 000000 000000 00.0
0000000 0000000000 10-Apr-2019 00000 00000 0000 Drug Discovery Generating Revenue 000000 000000 00.0
0000 00000000000 13-Dec-2018 00000 00000 000.00 Biotechnology Clinical Trials - Phase 1 000000 000000 00.0
00000 000000000000 29-Aug-2018 00000 00000 000.00 Biotechnology Generating Revenue 000000 0000000
0000000 0000000000 11-Apr-2018 00000 00000 000.00 Surgical Devices Generating Revenue/Not Profitable 0000000 00000 00
Macrolide Pharmaceuticals 02-Apr-2018 Early Stage VC 0000 Drug Discovery Pre-Clinical Trials 000000 000000 00.0
Iterum Therapeutics 16-Feb-2018 Early Stage VC 000.00 Drug Discovery Generating Revenue/Not Profitable 0000000 00000 00
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Advent Life Sciences’s full profile, request a free trial.

Advent Life Sciences Exits (31)

Company Name Exit Date Exit Type Exit Size Status Buyers
Vestagen 01-Jul-2019 Out of Business Completed
0000000 0000000000 31-Oct-2018 000 00000 Completed
000000 00000000000 25-May-2018 000 0000 Completed
0000000000 04-Apr-2018 000000000000000000 00000 Completed
  • 00000000
0000000 000 30-Jun-2017 000000000 00000000 Completed
0000000000 0000000 01-May-2016 000000000000000000 Completed
  • 0000 0000000000000
0000000 00000 0000 26-Aug-2015 000000000000000000 00000 Completed
  • 0000000 0000000000
000000000 20-Aug-2015 000000000000000000 Completed
  • 00000000 000000000
Cellnovo 10-Jul-2015 IPO 000.00 Completed
Biocartis 27-Apr-2015 IPO 00000 Completed
To view this investor’s complete exits history, request access »

Advent Life Sciences Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is reserved for PitchBook Platform accredited users. To explore Advent Life Sciences‘s full profile, request access.

Request full access to PitchBook

Advent Life Sciences Team (19)

Name Title Deals Funds Boards Office Contact
Info
Kaasim Mahmood General Partner 0 0 0 London, United Kingdom
Shahzad Malik MD General Partner 00 0 0 London, United Kingdom
Andrew Wood Venture Partner 0 London, United Kingdom
Donald Drakeman Ph.D Venture Partner London, United Kingdom
Naseem Amin MD Venture Partner London, United Kingdom

1 Former Team Member

You’re viewing 5 of 19 team members. Get the full list »

Advent Life Sciences Co-Investors (76)

Name With Exits Lead Partner
Henri Termeer 3 0
Longitude Capital 0 0
OrbiMed 0 0
Canaan Partners 0 0
Forbion 0 0
To view this investor’s complete co-investor history, request access »